City

Feldkirch (1)

Graz (1)

Innsbruck (1)

Linz (1)

Nanjing (1)

Salzburg (1)

Condition

Locally Advanced Carcinoma (2)

Esophageal Squamous Cell Carcinoma (1)

Metastatic Cancer (1)

Overall Status

Recruiting (2)

Sign in for free

Phase

n/a (1)

phase 2 (1)

Sponsor

Medical University of Graz (1)

The First Affiliated Hospital with Nanjing Medical University (1)

Collaborator

Intervention

5-fu (1)

biomarker monitoring (1)

cis platinum (1)

next generation sequencing (1)

tislelizumab (1)

Study Documents

Intervention Type

diagnostic test (1)

drug (1)

genetic (1)

Funder Type

Other (2)

Study Type

Interventional (2)

locally advanced carcinoma

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Esophageal Squamous Cell Carcinoma, Locally Advanced Carcinoma Trial in Nanjing (Tislelizumab, 5-FU, cis Platinum)

Recruiting

Esophageal Squamous Cell Carcinoma
Locally Advanced Carcinoma

Tislelizumab
+2 more

Nanjing, Jiangsu, China

Jiangsu Provincial People's Hospital

Jul 19, 2022

Locally Advanced Carcinoma, Metastatic Cancer Trial in Austria (Next Generation Sequencing, Biomarker Monitoring)

Recruiting

Locally Advanced Carcinoma
Metastatic Cancer

Next Generation Sequencing
Biomarker Monitoring

Innsbruck, Tirol, Austria
+4 more

Mar 10, 2022